Abstract: A dual release oral dosage system/dosage form comprising an immediate release component/composition and a delayed release component/composition is described. Each of the immediate release component/composition and delayed release component/composition comprises one or more of doxylamine, an analog thereof, a derivative thereof, a prodrug thereof, a metabolite thereof and/or a salt thereof, and one or more of pyridoxine, a salt thereof, a metabolite thereof and/or a salt of the metabolite. The dual release oral dosage system/dosage form exhibits an improved pharmacokinetic profile relative to the current Diclectin® formulation and is useful for example for the alleviation of the symptoms of nausea and vomiting, for example in the case of nausea and vomiting in pregnancy (NVP).

Abstract: Systems and methods for enhanced television interaction are disclosed. For example, one disclosed method includes receiving notification information, the notification information indicating an event associated with video content displayed by a television device; determining a haptic effect associated with the notification information; generating and transmitting a haptic signal to a haptic output device, the haptic signal configured to cause the haptic output device to output the haptic effect.

Abstract: A system is provided that generates a dynamic haptic effect that includes one or more key frames, where each key frame includes a first interpolant value and a first haptic effect. The system further receives an interpolant value, where the interpolant value is between at least two interpolant values of at least two key frames. The system further determines the dynamic haptic effect from the interpolant value. The system further distributes the dynamic haptic effect among a plurality of actuators.

Abstract: A method for compressing a stream by means of a codec (C), provided for assigning to a compressed stream an encoding throughput (Q) measured in bits per second, using a pre-filter (X1) replacing in the header (T1) of the original stream, the restoration frequency (R) with a frequency equal to the product (R×K) of the restoration frequency (R) by a coefficient (K) and then for retransmitting the thereby filtered stream (FX1) to the codec; the post-filter (X2) replacing the restoration frequency (R) into the header (TX2) of a stream (FX2) resulting from the encoding of the pre-filtered stream (FX1) by the codec C.

Abstract: Provided herein is a prenatal and postpartum multivitamin and mineral supplement package provided in the form of a plurality of solid oral dosage units individually contained in blister packs wherein a portion of the dosage forms are iron-containing while at least half of the dosage units are essentially iron-free and wherein the total amount of iron in the package as sold to purchasers is less than about 1300 mg of elemental iron.

Abstract: A micronutrient supplement the supplement being characterized by having at least two types of distinct dosage units wherein said distinct dosage units which physically separate nutritional, vitamin or mineral supplements which are known or proven to be negatively interacting when co-mingled or co-administered, the distinct dosage units being designed to be taken at a predetermined time interval.

Abstract: A method for differential compression of a sequence of digital values adapted to avoid error propagation during restoration of the values.

Abstract: A method for processing a digital file of the images, video and/or audio type which comprises a phase for putting into line per color layer and/or per audio channel, digital data of any audio, image and video file, a compression phase using algorithm in which each compressed value VCn of position N is obtained by subtracting from the value Vn of same position N of the original file, a predetermined number of successive compressed values (VCn-1, VCn-2, . . . ) calculated previously, and a restoration phase using an algorithm in which each restored value VDn of position N is obtained by adding to the value VCn, of the same position of the compressed file, a predetermined number of successive compressed values (VCn-1, VCn-2, . . . ).

Abstract: A haptic theme system is provided that can create a haptic theme, where a haptic theme is an installable package that includes one or more haptic effects, and a mapping of the one or more haptic effects to one or more user interface (“UI”) events of a device. The haptic theme can be installed on the device, and the device can then dynamically load and play a haptic theme in real-time. The haptic theme system can display one or more haptic themes within a user interface. Upon receiving a selection, the haptic theme system can generate haptic feedback based on the haptic effect that is mapped to a received user interface event within the mapping.

Abstract: The invention concerns a method comprising a coding step consisting in replacing the original values of the file with coding values of reduced brightness, a common coding value being attributed to a group of original values, a step of restitution consisting in setting correspondence values between the coding value and the restored value, selected from one of the values of the corresponding group, an insertion step consisting in modifying the successive redundant restored values so as to produce shades and a step which consists in reading the values resulting from the insertion step.

Abstract: A method for processing a digital file of the images, video and/or audio type which comprises a phase for putting into line per color layer and/or per audio channel, digital data of any audio, image and video file, a compression phase using algorithm in which each compressed value VCn of position N is obtained by subtracting from the value Vn of same position N of the original file, a predetermined number of successive compressed values (VCn-1, VCn-2, . . . ) calculated previously, and a restoration phase using an algorithm in which each restored value VDn of position N is obtained by adding to the value VCn, of the same position of the compressed file, a predetermined number of successive compressed values (VCn-1, VCn-2, . . . ).

Abstract: Provided herein is a prenatal and postpartum multivitamin and mineral supplement package provided in the form of a plurality of solid oral dosage units individually contained in blister packs wherein a portion of the dosage forms are iron-containing while at least half of the dosage units are essentially iron-free and wherein the total amount of iron in the package as sold to purchasers is less than about 1300 mg of elemental iron.

Abstract: A micronutrient supplement the supplement being characterized by having at least two types of distinct dosage units wherein said distinct dosage units which physically separate nutritional, vitamin or mineral supplements which are known or proven to be negatively interacting when co-mingled or co-administered, the distinct dosage units being designed to be taken at a predetermined time interval.

Abstract: A pharmaceutical dosage form comprising at least one active ingredient and destined for administration to pregnant women. The pharmaceutical dosage form bears pregnancy-friendly indicia apt to improve patient compliance with medically recommended dosage regimen resulting in improved product effectiveness. The pregnancy-friendly indicia is also apt to diminish the incidence of erroneous dispensing of or erroneous ingestion of pharmaceutical dosage forms not intended for pregnant women. Also disclosed is a method for achieving improved patient compliance resulting in improved product effectiveness. Also disclosed is a method for diminishing the incidence of erroneous dispensing of or erroneous ingestion of dosage forms not intended for pregnant women. Said methods comprising providing a pharmaceutical dosage form, intended for use by pregnant women, bearing pregnancy-friendly indicia apt to graphically distinguish dosage forms intended to be used during pregnancy from others.

Abstract: A pharmaceutical dosage form comprising at least one active ingredient and destined for administration to pregnant women. The pharmaceutical dosage form bears pregnancy-friendly indicia apt to improve patient compliance with medically recommended dosage regimen resulting in improved product effectiveness. The pregnancy-friendly indicia is also apt to diminish the incidence of erroneous dispensing of or erroneous ingestion of pharmaceutical dosage forms not intended for pregnant women. Also disclosed is a method for achieving improved patient compliance resulting in improved product effectiveness. Also disclosed is a method for diminishing the incidence of erroneous dispensing of or erroneous ingestion of dosage forms not intended for pregnant women. Said methods comprising providing a pharmaceutical dosage form, intended for use by pregnant women, bearing pregnancy-friendly indicia apt to graphically distinguish dosage forms intended to be used during pregnancy from others.

Abstract: A method and product for deployment-aware code generation in a distributed embedded system is described. The method generally comprises defining source and target component structural models by graphically modeling components and component structural features. The source component structural model is then mapped to the target component structural model to define a staging between the source and target component structural models, preferably also graphically. The staging is then combined with configurations of the source and target component structural models to fully specify a deployment from which code can be automatically generated for the embedded system. As opposed to platform-aware code generation that depends on the component and the platform on which the component is deployed, deployment-aware code generation depends not only on the location of the component being generated, but also on the location of other components.

Abstract: A pharmaceutical dosage form comprising at least one active ingredient and destined for administration to pregnant women. The pharmaceutical dosage form bears pregnancy-friendly indicia apt to improve patient compliance with medically recommended dosage regimen resulting in improved product effectiveness. The pregnancy-friendly indicia is also apt to diminish the incidence of erroneous dispensing of or erroneous ingestion of pharmaceutical dosage forms not intended for pregnant women. Also disclosed is a method for achieving improved patient compliance resulting in improved product effectiveness. Also disclosed is a method for diminishing the incidence of erroneous dispensing of or erroneous ingestion of dosage forms not intended for pregnant women. Said methods comprising providing a pharmaceutical dosage form, intended for use by pregnant women, bearing pregnancy-friendly indicia apt to graphically distinguish dosage forms intended to be used during pregnancy from others.

Abstract: A method for the preparation of pharmaceutical dosage forms comprising multiple powdered active ingredients, in a preferred embodiment, said method comprising the steps of mixing said active ingredients and at least one chosen excipient so as to obtain a powdered mixture; compacting said powdered mixture in a roller-compactor apparatus to obtain a compacted product; breaking and sieving said compacted product to a chosen mesh size to obtain similar sized granules; preferably dry mixing said granules with at least on chosen excipient so as to obtain a granular mixture; forming said granular mixture into unitary dosage forms.

Abstract: Provided herein is a prenatal and postpartum multivitamin and mineral supplement package provided in the form of a plurality of solid oral dosage units individually contained in blister packs wherein a portion of the dosage forms are iron-containing while at least half of the dosage units are essentially iron-free and wherein the total amount of iron in the package as sold to purchasers is less than about 1300 mg of elemental iron.

Abstract: A micronutrient supplement the supplement being characterized by having at least two types of distinct dosage units wherein said distinct dosage units which physically separate nutritional, vitamin or mineral supplements which are known or proven to be negatively interacting when co-mingled or co-administered, the distinct dosage units being designed to be taken at a predetermined time interval.